Disclosures for "Serostatus-stratified Efficacy of Monoclonal Antibodies in NMOSD: A Systematic Review and Meta-analysis"
-
Dr. Zammar has nothing to disclose.
-
Dr. AbuAlrob has nothing to disclose.
-
Dr. Safan has nothing to disclose.
-
Dr. Garcia Cañibano has nothing to disclose.
-
Dr. Hamid has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Merck Novartis .